| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.3B | $14.2B | $13.1B | $12.2B | $16.1B | $2.4B | $2.2B | $1.9B |
| Cost of Revenue | — | — | — | — | — | $0.4B | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $5.9B | $5.1B | $4.4B | $3.6B | $2.9B | $2.7B | $3.0B | $2.2B |
| SG&A Expense | $2.7B | $3.0B | $2.6B | $2.1B | $1.8B | $1.3B | $1.8B | $1.6B |
| Operating Income | $3.6B | $4.0B | $4.0B | $4.7B | $8.9B | $3.6B | $2.2B | $2.5B |
| Net Income | $4.5B | $4.4B | $4.0B | $4.3B | $8.1B | $1.1B | $0.8B | $0.8B |
| EPS (Basic) | $43.07 | $40.90 | $37.05 | $40.51 | $76.40 | $10.90 | $7.25 | $7.58 |
| EPS (Diluted) | $41.48 | $38.34 | $34.77 | $38.22 | $71.97 | $10.24 | $6.93 | $7.15 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $40.6B | $37.8B | $33.1B | $29.2B | $25.4B | $17.2B | $14.8B | $11.7B |
| Current Assets | $18.0B | $18.7B | $19.5B | $15.9B | $14.0B | $9.8B | $7.7B | $6.4B |
| Cash & Equivalents | $3.1B | $2.5B | $2.7B | $3.1B | $2.9B | $2.2B | $1.6B | $1.5B |
| Total Liabilities | $9.3B | $8.4B | $7.1B | $6.6B | $6.7B | $6.1B | $3.7B | $3.0B |
| Current Liabilities | $4.4B | $3.9B | $3.4B | $3.1B | $3.9B | $2.7B | $2.1B | $1.4B |
| Stockholders' Equity | $31.3B | $29.4B | $26.0B | $22.7B | $18.8B | $11.0B | $11.1B | $8.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.0B | $4.4B | $4.6B | $5.0B | $7.1B | $2.6B | $2.4B | $2.2B |
| Investing Cash Flow | $-0.6B | $-2.5B | $-3.2B | $-3.8B | $-5.4B | $-0.1B | $-2.0B | $-1.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-3.7B | $-2.2B | $-1.8B | $-1.0B | $-1.0B | $-2.0B | $-0.3B | $-0.1B |